Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Albany Research Institute, Inc.
Ketamine Low dOse Evaluation on Morphine Consumption in Traumatic Patient
Assistance Publique Hopitaux De Marseille
A Study of a Psilocybin Analog (CYB003) in Healthy Participants With and Without Major Depressive Disorder
Cybin IRL Limited
Chest Wall Block After Sternotomy: Randomized Controlled Trial in Cardiac Surgery: (PABLOS Study)
University Hospital, Angers
Food Effects on Bioavailability of MDMA in Healthy Volunteers
Lykos Therapeutics
Anhedonia, Development, and Emotions: Phenotyping and Therapeutics
Erika Forbes
Ketamine for Treatment-Resistant Bipolar Disorder
Joshua Rosenblat
Effects of Psilocybin in Post-Treatment Lyme Disease
Johns Hopkins University
An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics
Usona Institute
Dexmedetomidine Use in Infants Undergoing Cooling Due to Neonatal Encephalopathy (DICE Trial)
University of Utah
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder
COMPASS Pathways
OFA vs OBA in Bariatric Surgery
Hospital HM Nou Delfos
Comparison of Two Magnesium Sulfate Protocols in Opioid-Free Anesthesia for Bariatric Surgery
Hospital HM Nou Delfos
Investigation of Intranasal Ketamine Related Changes in Attentional Brain Networks With Functional and Structural MRI
Rupert Lanzenberger
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
ERP Biomarker Qualification Consortium
Opioid-free Vs Traditional Balanced Anesthesia in Laparoscopic Colorectal Surgery
Unai Ortega Mera
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
University of Chicago
Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
University of Texas Southwestern Medical Center
Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression
Centre for Addiction and Mental Health
Effects of LSD on Neuroplasticity in Healthy Subjects
University of Fribourg
Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
Washington University School of Medicine
Social Anxiety MDMA-Assisted Therapy Investigation
Jason B Luoma
Tolerance and Potential Synergistic Effect of the Combination of Intranasal Esketamine and Non-selective MAOI
University Hospital, Strasbourg, France
Randomized Trial of Sedative Choice for Intubation
Vanderbilt University Medical Center
Opioid-free Anesthesia and Thoracoscopy Surgery
Nantes University Hospital
Chart Review of Patients Undergoing Ketamine Treatments for Depression
Sunnybrook Health Sciences Centre
Effect of Ketamine on BIS Values
University of Padova
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sheppard Pratt Health System
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
University Hospital, Basel, Switzerland
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
TRYP Therapeutics
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Yvan Beaussant, MD, MSci
Frontline Clinician Psilocybin Study
University of Washington
Venous Cannulation Pain to Guide Choice of Anesthetic Method
Region Halland
Single Ascending Dose Study With BPL-003 in Healthy Subjects
Beckley Psytech Limited
Ketamine + Mindfulness for Depression
Rebecca Price
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Perception Neuroscience
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Definium Therapeutics US, Inc.
Effects of MDMA-like Substances in Healthy Subjects
University Hospital, Basel, Switzerland
Ketamine for the Treatment of Depression in Parkinson's Disease
Yale University
Psilocybin for Treatment-Resistant Depression
Brain and Cognition Discovery Foundation
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Celgene
Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
Hospices Civils de Lyon
Stanford Regulating Circuits of the Brain Study - MDMA
Stanford University
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Centre for Addiction and Mental Health
Synaptic Imaging and Network Activity in Treatment Resistant Depression
King's College London
Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry
Novartis
Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass
matthieu clanet
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
University of Utah
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.